ID   HX155c
AC   CVCL_L442
SY   HX155; Hx155; HX/155; HX/155c
DR   Cosmic; 687511
DR   Wikidata; Q54896981
RX   PubMed=2441858;
RX   PubMed=2475347;
RX   PubMed=2813837;
RX   PubMed=8347478;
RX   PubMed=35692560;
CC   Doubling time: 48 hours (Note=At 50th passage) (PubMed=2441858).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
RX   PubMed=2441858;
RA   Kelland L.R., Burgess L., Steel G.G.;
RT   "Characterization of four new cell lines derived from human squamous
RT   carcinomas of the uterine cervix.";
RL   Cancer Res. 47:4947-4952(1987).
//
RX   PubMed=2475347; DOI=10.1016/0277-5379(89)90417-3;
RA   Kelland L.R., Tonkin K.S.;
RT   "In vitro chemosensitivity of four new carcinoma of the cervix cell
RT   lines: relationship to radiosensitivity.";
RL   Eur. J. Cancer Clin. Oncol. 25:1211-1218(1989).
//
RX   PubMed=2813837; DOI=10.1016/0167-8140(89)90070-4;
RA   Tonkin K.S., Kelland L.R., Steel G.G.;
RT   "A comparison of the in vivo and in vitro radiation response of three
RT   human cervix carcinomas.";
RL   Radiother. Oncol. 16:55-63(1989).
//
RX   PubMed=8347478; DOI=10.1038/bjc.1993.322; PMCID=PMC1968570;
RA   Mellish K.J., Kelland L.R., Harrap K.R.;
RT   "In vitro platinum drug chemosensitivity of human cervical squamous
RT   cell carcinoma cell lines with intrinsic and acquired resistance to
RT   cisplatin.";
RL   Br. J. Cancer 68:240-250(1993).
//
RX   PubMed=35692560; DOI=10.1080/23723556.2022.2078628; PMCID=PMC9176225;
RA   de Lourdes Zuniga-Martinez M., Lopez-Mendoza C.M., Tenorio-Salazar J.,
RA   Garcia-Carranca A.M., Cerbon-Cervantes M.A., Alcantara-Quintana L.E.;
RT   "Establishment, authenticity, and characterization of cervical cancer
RT   cell lines.";
RL   Mol. Cell. Oncol. 9:2078628.1-2078628.10(2022).
//